Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

398
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
398
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

244
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
244
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

353
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
353
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

216
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
216
Pharmaceutical Equivalents01:26

Pharmaceutical Equivalents

260
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
260
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

1.4K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

THE RIDDLE OF THE WALL IN THE BRAIN.

Fortune·2016
Same journal

BLOOD TESTING IS BOOMING.

Fortune·2016
Same journal

INTO THE LIGHT.

Fortune·2016
Same journal

BIG INNOVATION IN SMALL PLACES.

Fortune·2016
Same journal

HACKER BAD BOY VENTURE CAPITALIST DISRUPTER HEALER.

Fortune·2016
Same journal

THE FIGHT TO DOMINATE BIG PHARMA(CY).

Fortune·2016

Related Experiment Video

Updated: Apr 6, 2026

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
10:49

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Published on: June 16, 2022

3.1K

CAN DRUGMAKERS LIVE WITHOUT MERGERS?

Yen Wieczner

    Fortune
    |August 6, 2015
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues
    08:07

    Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues

    Published on: April 7, 2023

    4.6K
    Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers
    09:44

    Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers

    Published on: July 7, 2023

    5.3K

    Related Experiment Videos

    Last Updated: Apr 6, 2026

    Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
    10:49

    Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

    Published on: June 16, 2022

    3.1K
    Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues
    08:07

    Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues

    Published on: April 7, 2023

    4.6K
    Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers
    09:44

    Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers

    Published on: July 7, 2023

    5.3K